[Clinical effects of COG-78 on severe infections complicated with hematopoietic diseases--a comparative study on cross-over method].
D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007275:Injections, Intravenous; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage
D000900:Anti-Bacterial Agents; C040662:COG-78; D007136:Immunoglobulins; D011092:Polyethylene Glycols